Ever Source Wealth Advisors, LLC Krystal Biotech, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.48 Billion
- Q3 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 29 shares of KRYS stock, worth $5,144. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29
Previous 35
17.14%
Holding current value
$5,144
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding KRYS
# of Institutions
308Shares Held
24.5MCall Options Held
484KPut Options Held
309K-
Black Rock Inc. New York, NY3.95MShares$700 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.85MShares$506 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.62MShares$465 Million7.18% of portfolio
-
State Street Corp Boston, MA1.45MShares$258 Million0.01% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA988KShares$175 Million9.67% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.55B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...